| scholarly article | Q13442814 |
| P2093 | author name string | Okamoto K | |
| Nakamura S | |||
| Kameyama M | |||
| Suga H | |||
| Fujiyoshi K | |||
| P2860 | cites work | Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity | Q29618557 |
| CSF and plasma vasopressin concentrations in dementia | Q33619218 | ||
| Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis | Q34717505 | ||
| Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates | Q39255971 | ||
| The effects of vasopressin on memory processes: The role of noradrenergic neurotransmission | Q39289304 | ||
| Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa | Q40083223 | ||
| Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat | Q40856804 | ||
| Extrahypothalamic vasopressin is unchanged in Parkinson's disease and Huntington's disease. | Q45304501 | ||
| Radioimmunoassay for GH-Release Inhibiting Hormone | Q48472520 | ||
| Abnormal behavioural changes associated with vasopressin-induced barrel rotations | Q48522732 | ||
| Arginine-vasopressin content of hippocampus and amygdala during passive avoidance behavior in rats. | Q48705591 | ||
| Vasopressin-immunoreactive cell bodies in the bed nucleus of the stria terminalis of the rat | Q48837472 | ||
| THE INFLUENCE OF THE POSTERIOR AND INTERMEDIATE LOBE OF THE PITUITARY AND PITUITARY PEPTIDES ON THE MAINTENANCE OF A CONDITIONED AVOIDANCE RESPONSE IN RATS. | Q51251907 | ||
| Lysine vasopressin in Alzheimer disease. | Q52220784 | ||
| Effects of vasopressin on human memory functions. | Q52226345 | ||
| Changes in the brain catecholamines in patients with dementia of Alzheimer type. | Q53178323 | ||
| Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type | Q53196325 | ||
| Cell loss in the locus coeruleus in senile dementia of Alzheimer type. | Q53199035 | ||
| Arginine vasopressin and choline acetyltransferase in brains of patients with Alzheimer type senile dementia | Q53307972 | ||
| Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide. | Q53310418 | ||
| Extrahypothalamic vasopressin in human brain | Q70789048 | ||
| Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type | Q70918123 | ||
| Separation of vasopressin analogues by reversed-phase high-performance liquid chromatography | Q71213657 | ||
| Vasopressin content of rat brain | Q71337159 | ||
| Dopamine-beta-hydroxylase activities in serum and cerebrospinal fluid of aged and demented patients | Q71360933 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| senile dementia | Q11610626 | ||
| AVP | Q12009087 | ||
| P304 | page(s) | 929-932 | |
| P577 | publication date | 1987-07-01 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia | |
| P478 | volume | 50 |
| Q21651042 | A Novel Prolyl Endopeptidase Inhibitor, JTP-4819 - Its Behavioral and Neurochemical Properties for the Treatment of Alzheimer's Disease |
| Q52044089 | A novel prolyl endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer's disease. |
| Q43170220 | Arginine vasopressin prevents against Abeta(25-35)-induced impairment of spatial learning and memory in rats |
| Q49142614 | Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain |
| Q42478368 | Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and on cholinergic and peptidergic neurons in rats with ibotenate-induced lesions of the nucleus basalis magnocellularis |
| Q40472392 | Hormonal Aspects of Fluid and Sodium Balance in the Elderly |
| Q34688145 | Neurohypophyseal peptides in aging and Alzheimer's disease |
| Q37948072 | Neuropeptides and Alzheimer's disease |
| Q36501962 | Neurotransmitters and Neuropeptides in Alzheimer's Disease |
| Q36055312 | Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study |
| Q48918674 | Vasopressin response to dehydration in Alzheimer's disease |
| Q36639258 | Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease |
Search more.